Regulatory Aspects for Approval of Advanced Therapy Medicinal Products in the EU
Shayesteh Fürst-Ladani, Anja Bührer, Walter Fürst, Nathalie Schober-Ladani
Topics & Concepts
Marketing authorizationAuthorizationBusinessEuropean unionProduct (mathematics)Orphan drugAgency (philosophy)IncentiveMarketingRisk analysis (engineering)International tradeComputer securityComputer scienceEconomicsEpistemologyBioinformaticsMathematicsPhilosophyBiologyMicroeconomicsGeometryBiomedical Ethics and RegulationCRISPR and Genetic EngineeringHealth Systems, Economic Evaluations, Quality of Life